Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

413 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literature.
Jarius S, Ruprecht K, Stellmann JP, Huss A, Ayzenberg I, Willing A, Trebst C, Pawlitzki M, Abdelhak A, Grüter T, Leypoldt F, Haas J, Kleiter I, Tumani H, Fechner K, Reindl M, Paul F, Wildemann B. Jarius S, et al. Among authors: reindl m. J Neuroinflammation. 2018 Mar 19;15(1):88. doi: 10.1186/s12974-018-1108-6. J Neuroinflammation. 2018. PMID: 29554927 Free PMC article. Review.
Antibody response to myelin oligodendrocyte glycoprotein and myelin basic protein depend on familial background and are partially associated with human leukocyte antigen alleles in multiplex families and sporadic multiple sclerosis.
Lutterotti A, Reindl M, Gassner C, Poustka K, Schanda K, Deisenhammer F, Berger T. Lutterotti A, et al. Among authors: reindl m. J Neuroimmunol. 2002 Oct;131(1-2):201-7. doi: 10.1016/s0165-5728(02)00271-0. J Neuroimmunol. 2002. PMID: 12458053
Epitope specificity of serum antibodies directed against the extracellular domain of myelin oligodendrocyte glycoprotein: Influence of relapses and immunomodulatory treatments.
Khalil M, Reindl M, Lutterotti A, Kuenz B, Ehling R, Gneiss C, Lackner P, Deisenhammer F, Berger T. Khalil M, et al. Among authors: reindl m. J Neuroimmunol. 2006 May;174(1-2):147-56. doi: 10.1016/j.jneuroim.2006.01.012. Epub 2006 Mar 6. J Neuroimmunol. 2006. PMID: 16516980 Clinical Trial.
Increased serum levels of soluble CD14 indicate stable multiple sclerosis.
Lutterotti A, Kuenz B, Gredler V, Khalil M, Ehling R, Gneiss C, Egg R, Deisenhammer F, Berger T, Reindl M. Lutterotti A, et al. Among authors: reindl m. J Neuroimmunol. 2006 Dec;181(1-2):145-9. doi: 10.1016/j.jneuroim.2006.09.002. Epub 2006 Oct 13. J Neuroimmunol. 2006. PMID: 17046070
Biological markers for multiple sclerosis.
Lutterotti A, Berger T, Reindl M. Lutterotti A, et al. Among authors: reindl m. Curr Med Chem. 2007;14(18):1956-65. doi: 10.2174/092986707781368478. Curr Med Chem. 2007. PMID: 17691938 Review.
413 results